Microbes in Allergy and Autoimmunity Related to the Skin
Allergy and autoimmunity cause increasing burden to societies worldwide. We study the effect of microbiome on the skin, the forefront barrier to environment, on autoimmunity and allergy, using atopic dermatitis (AD) and psoriasis...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2010-16240
METAGENOMAS PROCARIOTAS DE LA PIEL HUMANA SANA Y CON PSORIAS...
30K€
Cerrado
META-BIOME
Deciphering the molecular language orchestrating host microb...
2M€
Cerrado
PID2021-125106OB-C31
VARIANTES POST-CIGOTICAS RESPONSABLES DE MOSAICISMO GENETICO...
218K€
Cerrado
INTERACT
Skin microbial metabolites and antimicrobial peptides at the...
226K€
Cerrado
MISTRAL
Microbiome based stratification of individuals at risk of HI...
10M€
Cerrado
IMMUNOBIOME
Identifying microbiotal triggers of inflammatory bowel disea...
2M€
Cerrado
Información proyecto MAARS
Líder del proyecto
TYOTERVEYSLAITOS
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
8M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Allergy and autoimmunity cause increasing burden to societies worldwide. We study the effect of microbiome on the skin, the forefront barrier to environment, on autoimmunity and allergy, using atopic dermatitis (AD) and psoriasis (PSO) as paradigmatic examples. We have detailed information about the genetic risk factors, as well as the molecular and cellular players in AD and PSO, but we know very little how microbe-host interaction triggers and regulate inflammatory cascade leading to allergic or autoimmune reaction. We propose that environmental and genetic factors, characteristic to particular disease, initiate a cascade of inflammatory events through the modulation of anti-microbial defence. The dysregulation of innate as well as adaptive immune responses leads to inappropriate responses to physical, microbial or allergen challenge, finally manifesting in the clinical symptoms of AD or PSO. We propose to use high-throughput whole microbiome and transcriptomics analysis with bioinformatics and systems biology to unravel the pathways during the host-pathogen interactions which may trigger an allergic or autoimmune reaction. We will identify key microbes and molecular targets to develop novel intervention strategies to decrease and prevent the burden of allergy and autoimmunity.